MedTrace Logo

Estradiol Patch as add-on to Antipsychotics in Patients With Schizophrenia, Schizoaffective or Schizophreniform Disorder

NCT03848234 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 209

Last updated 2020-05-22

No results posted yet for this study

Summary

To evaluate the effects of Estradiol patches vs placebo patches as add-on to antipsychotics on psychometric performance in patients with schizophrenia, schizoaffective or schizophreniform disorder

Conditions

  • Schizophrenia
  • Schizoaffective Disorder
  • Schizophreniform Disorders

Interventions

DRUG

Estradiol

2 trans dermal patches to be changed twice a week for the duration of 8 weeks.

DEVICE

Placebo

2 trans dermal patches to be changed twice a week for the duration of 8 weeks.

Sponsors & Collaborators

  • Stanley Medical Research Institute

    collaborator OTHER

  • Tangent Data

    lead OTHER

Principal Investigators

  • Paull G Radu, M.D. · Tangent Data

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-04
Primary Completion
2016-07-29
Completion
2016-07-29

Countries

  • Moldova

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03848234 on ClinicalTrials.gov